Product Program year 2021 Source: CMS Open Payments

Percepta

Device Cardiac Resynchronization Therapy - CRT

PDI 00643169735644

Open in the dashboard

General payments

$2,273

165 payments

Research payments

$0

0 payments

Through program year 2021, $2,273 in general payments and $0 in research payments were reported against Percepta (Cardiac Resynchronization Therapy - CRT).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2021 General $2,273 165

Breakdown

Who paid General payments · program year 2021
  1. Medtronic, Inc. $2,273 165 payments
Top recipients General payments · program year 2021
  1. Harlan Grogin Clinical Cardiac Electrophysiology · Salinas, CA $156 7% · 16 payments
  2. Olusegun Olusesi Clinical Cardiac Electrophysiology · Norfolk, VA $101 4% · 1 payment
  3. Edward Lynch Cardiovascular Disease · Suffolk, VA $101 4% · 1 payment
  4. Eric Taylor Clinical Cardiac Electrophysiology · McAllen, TX $72 3% · 7 payments
  5. Bianca Arevalo Nurse Practitioner · Edinburg, TX $65 3% · 5 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Clinical Cardiac Electrophysiology Internal Medicine $1,117 50% · 51 practitioners
  2. Cardiovascular Disease Internal Medicine $490 22% · 22 practitioners
  3. Interventional Cardiology Internal Medicine $341 15% · 17 practitioners
  4. Physician Assistant $109 5% · 5 practitioners
  5. Nurse Practitioner $65 3% · 1 practitioner

The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Texas $447 20% · 14 recipients
  2. California $441 19% · 15 recipients
  3. Virginia $343 15% · 8 recipients
  4. Florida $291 13% · 18 recipients
  5. Kansas $235 10% · 12 recipients

The top 5 of 17 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

165 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record